Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CENTOGENE

CENTOGENE
2006 FOUNDED
PUBLIC STATUS
301-400 EMPLOYEES
CNTG STOCK SYMBOL
$13.66 SHARE PRICE (As of Friday Closing)
Description

CENTOGENE NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.

Formerly Known As
Centogene Holding, Arcensus
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Diagnostic Equipment
Medical Supplies
Stock Exchange
NAS
Primary Office
  • Am Strande 7
  • 18055 Rostock
  • Germany

+49 0381 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CENTOGENE’s full profile, request a free trial.

CENTOGENE Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$7.80 - $15.59 $271M $13.97 -$1.10 68.1K 19.9M

CENTOGENE Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Revenue 49,233 47,767 35,738 30,606
EBITDA (12,687) (6,409) (1,374) (3,185)
Net Income (21,805) (13,380) (6,176) (5,928)
Total Assets 80,731 87,708 66,567
Total Debt 25,493 22,511 23,203 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CENTOGENE Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore CENTOGENE‘s full profile, request access.

Request full access to PitchBook

CENTOGENE Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore CENTOGENE‘s full profile, request access.

Request full access to PitchBook

CENTOGENE Executive Team (8)

Name Title Board
Seat
Contact
Info
Arndt Rolfs MD Chief Executive Officer & Founder
Richard Stoffelen Chief Financial Officer & Executive
Dirk Ehlers Ph.D Chief Operating Officer & Executive
Sun Kim Ph.D Executive & Chief Strategy Officer
Volkmar Weckesser Ph.D Chief Information Officer & Executive

1 Former Executive

You’re viewing 5 of 8 executives. Get the full list »

CENTOGENE Board Members (9)

Name Representing Role Since Contact
Info
Berndt Modig Self Board Member 000 0000
Christoph Ehlers CENTOGENE Founder & Board Member 000 0000
Daniel Parera MD TVM Capital Life Science Supervisory Board Member 000 0000
Eric Souetre Ph.D Careventures Supervisory Board Member 000 0000
Flemming Ornskov MD CENTOGENE Chairman & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »